Digital Health

Cybersecurity
- Uncategorized
Digital patient management
Digital policy & regulation
Healthcare Innovation
ICT and Health
Tech & Pharma
Tech companies & Data

Sort by Product ID

Click to order products descending

Display 15 Products per page

Interventional Neurology: Cerebral Aneurysm and Arteriovenous Malformation Systems

$4,750.00

This medical market and technology report provides a comprehensive discussion of the global market for neurointerventional cerebral aneurysm and AVM embolization systems. This market comprises the following product segments: endovascular coils, liquid embolics, stents for stent-assisted coiling, flow diversion and flow disruption systems, and other novel/emerging embolization devices. Markets covered by this analysis comprise the US, Japan, the five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW) markets. The forecast range for this report is 2020–25.
December 21, 2021
Find out more
Abbott Launches New App To Keep Heart Failure Patients Out Of The Hospital

$131.00

Abbott’s Merlin patient care network works with the CardioMEMS HF sensor system. The Merlin 10.0 update to the network allows physicians to share custom messages directly with their patients. Medtech Insight looks closer at the software and its intended benefits.
September 2, 2019
Find out more
Serious Skin Reactions Reported with Ibuprofen Use in Europe

$131.00

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee advises ibuprofen manufacturers to add warnings on patient information leaflets concerning acute generalized exanthematous pustulosis associated with use of the drug. HBW provides details about the skin reaction being noted and the informational changes required.
September 2, 2019
Find out more
How To Pay For The New Wave Of Gene Therapies

$131.00

Pink Sheet spoke with Paul Goudreau, executive director & head of Phase IV Solutions at the CRO Covance, who says, “an ongoing and wide-ranging discussion is needed about assessment, payment and reimbursement of innovative products, as well as the evidence that supports them.”
August 3, 2019
Find out more
Contamination In Common OTC Antacid Adds To FDA’s API Impurity Concerns

$131.00

The US Food and Drug Administration is considering how to respond after a contaminant was found in drugs containing, ranitidine, the active ingredient in Sanofi’s Zantac OTC heartburn remedy and multiple generic equivalents. HBW also looks at similar investigations in Europe
August 2, 2019
Find out more
US Zantac Sales And Distribution Continue As Sanofi Tests For NDMA

$200.00

Sanofi plans to continue distributing Zantac OTC heartburn remedy in the US while conducting its own tests to determine whether levels of N-nitrosodimethylamine (NDMA) in the active ingredient are above safe levels, Novartis AG, which licenses OTC Zantac, has said it stopped distribution worldwide.
August 2, 2019
Find out more
Virtual AI Nurses And The Future Of Chronic Disease Management

$200.00

What’s in store for chronic disease management in the future? Tap into this informal discussion with health entrepreneur Julia Hu, founder of Lark Health, for a look at her views of what’s to come, including the use of artificial intelligence nursing.
March 6, 2019
Find out more
Patient-Specific Drive Takes Ortho Group Corin Into TKR Robotics With Omni Purchase

$131.00

Knee and hip replacement company Corin Group PLC has acquired Omni Orthopedics Inc. The acquisition of Omni, which specializes in robotic-assisted total knee replacement, marks another major step in the company’s expansion in the orthopedic market.
March 6, 2019
Find out more
Burt’s Bees Hopes Third Time’s A Charm For Toothpaste, This One With P&G

$131.00

Burt’s Bees is making another foray into the toothpaste category with a line for adults and children and a strategic licensing partnership with Procter & Gamble, makers of Crest. Discover the details of this third attempt to successfully enter the oral care space by the Clorox-owned Burt’s Bees.
January 5, 2019
Find out more
Going ‘Beyond The Pill’ – Sanofi To Partner With Digital Health Start-ups In Europe

$131.00

Sanofi and the Plug and Play venture fund are teaming up to explore digital technologies in the areas of nutrition and allergies. HBW Insight takes a deeper look at this partnership, as the pharma giant looks to take a lead role in European digital health innovation.
January 24, 2019
Find out more
Germany Begins The Year With Two Possible Rx-To-OTC Switches

$131.00

During their bi-annual meeting, Germany’s Expert Committee for Prescription was set to discuss a move from prescription to OTC status for hydrocortisone 1% for external use, and combination ibuprofen and phenylephrine hydrochloride. Get the details of the proposal with reporting from HBW Insight.
January 4, 2019
Find out more
Real-World Evidence Takes Courage: A Conversation With IQVIA’s Nancy Dreyer

$200.00

The 21st Century Cures Act’s call for the use of real-world evidence (RWE) is slowly moving toward reality. But hurdles abound, warns IQVIA’s Nancy Dreyer. For instance, the FDA–which is behind the EMA in this area–appears split. Privacy concerns and lack of interoperability hinder progress. Learn why this sometimes-muddied distinction between randomized clinical trial data and RWE is so important, and find out RWE’s role in label expansions.
February 11, 2019
Find out more
Market Intel: Needle-Free Glucose Monitoring, Digital Solutions Are Game-Changers In Growing Diabetes- Monitoring Market

$200.00

The continuous glucose monitoring (CGM) segment of the diabetes management market is exploding, while big names in the blood glucose monitoring (BGM) sector are facing increased competition from lower-cost developers and related innovative diabetes-monitoring products. Examine the competitive landscape for CGM and BGM in this informative Medtech Insight article.
December 6, 2018
Find out more
Pfizer’s Reference Point on Trial Innovation : Ask the Patient

$200.00

In this interview with Pfizer’s head of clinical innovation, Craig Lipset, learn why clinical trial innovation requires a patient-centered approach and how Pfizer is making this happen. Learn why patient-centricity matters. Explore how the digital revolution is reshaping patient engagement, data collection and the shape of clinical trials.
May 9, 2018
Find out more
Next-Generation Roche: How Data Analytics Will Keep It In The Lead In Oncology

$200.00

At Roche’s on-site investors briefing at ASCO in 2018, company execs unveiled the oncology leader’s strategy for staying ahead in the market: heavy investment in digital and personalized healthcare. Read more about the company’s plans in this illuminating article from Scrip.
June 8, 2018
Find out more

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726

Call Back

Name

Email *

Company name *

Phone number *